Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dm1, Maytansinoid
2. Dm4, Maytansinoid
3. Dmmo Maytansine
4. Dmmo-maytansine
5. Emtansine
6. Maitansine
7. Maytansine
8. Maytansinoid Dm1
9. Maytansinoid Dm4
10. N2'-deacetyl-n2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine
11. Ravtansine
12. Soravtansine
1. Maytansinoid Dm 1
2. Maytansinoid Dm1
3. 139504-50-0
4. Mertansine (dm1)
5. N2'-deacetyl-n2'-(3-mercapto-1-oxopropyl)-maytansine
6. Ddz29hgh0e
7. Dm1
8. Dm 1
9. [(1s,2r,3s,5s,6s,16e,18e,20r,21s)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl] (2s)-2-[methyl(3-sulfanylpropanoyl)amino]propanoate
10. Maytansine, N2'-deacetyl-n2'-(3-mercapto-1-oxopropyl)-
11. N2'-deacetyl-n2'-(3-mercapto-1-oxopropyl)-maytansine, L-
12. Dm1 [maytansinoid]
13. Dm 1 [maytansinoid]
14. Unii-ddz29hgh0e
15. Mertasine
16. Dm1;maytansinoid
17. Maytansinoid Dm1
18. Maytansinoid Dm1 [mi]
19. Chembl4802230
20. Schembl13558634
21. Chebi:82755
22. Mfcd28398157
23. S6773
24. Zinc95627837
25. Cs-5804
26. Da-48536
27. Hy-19792
28. J3.653.420f
29. Q4515649
30. (1s,2r,3s,5s,6s,16e,18e,20r,21s)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1(10,14).0(3,5)]hexacosa-10(26),11,13,16,18-pentaen-6-yl (2s)-2-[methyl(3-sulfanylpropanoyl)amino]propanoate
31. (3s)-3-o-de[2-(acetylmethylamino)-1-oxopropyl]-3-o-[(2s)-2-(methyl 3-mercaptopropanoylamino)propanoyl]maytansine
Molecular Weight | 738.3 g/mol |
---|---|
Molecular Formula | C35H48ClN3O10S |
XLogP3 | 2.2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 8 |
Exact Mass | 737.2748936 g/mol |
Monoisotopic Mass | 737.2748936 g/mol |
Topological Polar Surface Area | 158 Ų |
Heavy Atom Count | 50 |
Formal Charge | 0 |
Complexity | 1340 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antineoplastic Agents, Phytogenic
Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)
Tubulin Modulators
Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35973
Submission : 2021-06-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36200
Submission : 2021-08-13
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31393
Submission : 2017-11-21
Status : Active
Type : II
ABOUT THIS PAGE
A Maytansinoid DM1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Maytansinoid DM1, including repackagers and relabelers. The FDA regulates Maytansinoid DM1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Maytansinoid DM1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Maytansinoid DM1 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Maytansinoid DM1 supplier is an individual or a company that provides Maytansinoid DM1 active pharmaceutical ingredient (API) or Maytansinoid DM1 finished formulations upon request. The Maytansinoid DM1 suppliers may include Maytansinoid DM1 API manufacturers, exporters, distributors and traders.
click here to find a list of Maytansinoid DM1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Maytansinoid DM1 DMF (Drug Master File) is a document detailing the whole manufacturing process of Maytansinoid DM1 active pharmaceutical ingredient (API) in detail. Different forms of Maytansinoid DM1 DMFs exist exist since differing nations have different regulations, such as Maytansinoid DM1 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Maytansinoid DM1 DMF submitted to regulatory agencies in the US is known as a USDMF. Maytansinoid DM1 USDMF includes data on Maytansinoid DM1's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Maytansinoid DM1 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Maytansinoid DM1 suppliers with USDMF on PharmaCompass.
Maytansinoid DM1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Maytansinoid DM1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Maytansinoid DM1 GMP manufacturer or Maytansinoid DM1 GMP API supplier for your needs.
A Maytansinoid DM1 CoA (Certificate of Analysis) is a formal document that attests to Maytansinoid DM1's compliance with Maytansinoid DM1 specifications and serves as a tool for batch-level quality control.
Maytansinoid DM1 CoA mostly includes findings from lab analyses of a specific batch. For each Maytansinoid DM1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Maytansinoid DM1 may be tested according to a variety of international standards, such as European Pharmacopoeia (Maytansinoid DM1 EP), Maytansinoid DM1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Maytansinoid DM1 USP).
LOOKING FOR A SUPPLIER?